Geovax (GOVX) is a microcap biotech stock trading on the NASDQ stock exchange. Since August 2021, without significant negative news or unfavorable company developments, the company's share price has been reduced from $7.5 to nearly $0.50. Like many small publicly traded companies, Geovax is a victim of widespread, predatory, illegal short-selling activities that occur every day in US equities markets. These include but are not limited to, naked-short selling  "phantom" shares, abusing FTD regulations, disseminating false negative news media about company, and collusion of hedge funds and market makers to manipulate share price. We ask that the company duly and thoroughly investigate any and all ongoing illegal and nefarious trading activity of its GOVX stock and take the necessary actions to stop it.

Thank you,

GOVX Shareholders